{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-26-000015","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2026-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.076067+00:00","generated_at":"2026-05-15T04:27:07.700754+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Ana Hooker resigns from Exagen board, effective April 17, 2026","bullets":["Ana Hooker resigned as director and chair of Nominating and Corporate Governance Committee, also member of Audit Committee.","Resignation was not due to any disagreement with Exagen on operations, policies, or practices.","Board size reduced from 8 to 7 members effective April 17, 2026.","Paul Kim, Scott Kahn, Bruce Robertson, Frank Stokes, Charles McKhann remain with updated committee assignments."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-26-000015","json":"https://secwatch.observer/filing/0001274737-26-000015.json","markdown":"https://secwatch.observer/filing/0001274737-26-000015.md","text":"https://secwatch.observer/filing/0001274737-26-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473726000015/0001274737-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473726000015/exdx-20260417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:27:07.700754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}